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Background/aim: Escherichia coli is the most frequent cause of urinary tract infections. We investigated the possible associations
between the origin of strains, antimicrobial resistance, the presence of urovirulence factors, and biofilm-forming ability.
Materials and methods: Antibiotic susceptibility of E. coli strains was tested by disk diffusion method. Hemagglutination assays
were performed for phenotypic characterization of the cell surface. Multiplex PCR was used for detection of virulence genes and for
determination of phylogenetic relationships.
Results: The resistance to ampicillin (55.5%) and tetracycline (39.3%) was significantly more frequent than to other antimicrobial
agents. The fim gene was present in 92.5% of strains. The sfa and pap genes were found in 53.8% and 38.7% of strains, respectively.
The pap gene was significantly less frequently detected in strains from dialysis patients. The hly gene was present in 18.5% of strains.
The aer gene was detected in 52.6% and cnf in 12.1%, while afa was detected in 4.6% of strains. Most strains belonged to the B2 and D
phylogenetic groups. The aer gene was significantly associated with strains producing strong biofilms.
Conclusion: The E. coli strains causing cystitis in hospitalized patients differed in terms of resistance to antibiotics, virulence genes, and
potential for biofilm formation.
Key words: Uropathogenic Escherichia coli, antibiotic resistance, virulence genes, biofilm, phylogenetic groups

1. Introduction
Escherichia coli is the major factor of community-acquired
urinary tract infection (UTI) (70%–95%) and a large part of
nosocomial UTIs (50%). The virulence factors responsible
for pathogenesis outside of the gastrointestinal tract
belong to various functional groups. They include fimbrial
adhesins (e.g., P, S, and type 1 fimbriae), afimbrial adhesin
Afa I, toxins (e.g., α-hemolysin, cytotoxic necrotizing
factor 1 – CNF1), and iron acquisition systems (e.g.,
the aerobactin system) (1). The formation of biofilm is
another pathogenic mechanism, allowing E. coli to persist
in the genitourinary tract and hindering the eradication
of microorganisms. Different bacterial species colonize
urinary catheters and bacterial biofilm is the primary
factor for the development of nosocomial UTIs (2). These
infections are often difficult to treat and they are a major
reservoir of resistant pathogens (3).
In the present study, we compared the antimicrobial
resistance of E. coli strains causing cystitis in hospitalized
* Correspondence: barbara.kot@uph.edu.pl
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patients in different units of the hospital. We also
determined the possible relationships between the origin of
strains, the presence of urovirulence factors, phylogenetic
group, and biofilm formation on urinary catheters.
2. Materials and methods
2.1. Bacterial strains
A total of 173 E. coli strains were isolated from urine
samples of patients with cystitis. These strains were
derived from the urine samples of symptomatic patients
in which ≥105 colony-forming units of E. coli per milliliter
were found. Strains were collected from January 2007
through December 2008 from five groups of patients
hospitalized in internal, pediatric, neurological, obstetric
(pregnant women), and dialysis units of a district hospital.
E. coli identification was performed according to standard
procedures (4). The identification of the strains was
confirmed by using the ID 32 E system (bioMérieux).
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2.2. Antimicrobial susceptibility testing
The antimicrobial susceptibility of the strains was tested
by disk diffusion method (5). Extended-spectrum
β-lactamase (ESBL) production was detected using the
double disk synergy test (6).
E. coli ATCC 25922 and E. coli ATCC 35218 were used
as control strains.
2.3. Phenotypic characterization of the cell surface
The strains were grown on trypticase soy agar (TSA; BBL,
Becton Dickinson) at 37 °C for 24 h. Hemagglutination
assays were performed using human O group, sheep, calf,
guinea pig, adult chicken, and pig erythrocytes as described
previously (7). The presence of type 1 fimbriae was defined
by mannose-sensitive hemagglutination (MSHA), whereas
the presence of P, S, and other adhesins was determined by
mannose-resistant hemagglutination (MRHA).
2.4. Detection of virulence genes by PCR
Genomic DNA was isolated from E. coli strains by using
the Genomic Mini (A&A Biotechnology, Gdynia, Poland)
according to the manufacturer’s protocol.
The presence of the pap (encoding P fimbriae), sfa (S
fimbriae), afa (Afa I), hly (α-hemolysin), aer (aerobactin),
and cnf (CNF1) genes was investigated by multiplex PCR.
The specific primers are shown in Table 1.
2.5. Phylogenetic analysis
The phylogenetic group (A, B1, B2, and D) was determined
by triplex PCR performed with a combination of three
DNA markers (chuA, yjaA, and the DNA fragment TSPE4.
C2) (11).

2.6. Biofilm formation assay
Biofilm formation by E. coli strains on a silicone 20-Fr
Foley catheter (Romed, Herenweg, the Netherlands) was
analyzed using a procedure previously described (12).
2.7. Statistical analyses
Chi-square statistics in Statistics 9.0 (Analytical Software,
Tallahassee, FL, USA) was used for analysis. Differences at
P ≤ 0.05 were considered statistically significant.
3. Results
3.1. Antimicrobial resistance
More than half of E. coli (55.5%) exhibited phenotypic
resistance to ampicillin and the resistance to this
antibiotic was significantly more frequent than to other
antimicrobial agents. Numerous strains were resistant to
tetracycline (39.3%) and the percentage of strains resistant
to this antibiotic was highly significantly higher than to the
remaining antimicrobial agents (Figure). The resistance
to ampicillin occurred significantly less in the strains
from pregnant women (10%) than internal medicine
patients (60.9%) (P = 0.008) and also significantly less
in the strains from children (57.4%) (P = 0.016) and
neurological patients (57.7%) (P = 0.028) (Table 2). The
resistance to piperacillin was significantly less detected
among the strains from children (7.4%) than internal
medicine (32.8%) (P = 0.002) and dialysis patients (31.6%)
(P = 0.025) (Table 2). The resistance to cephalothin was
detected significantly more frequently in the strains from
internal medicine (20.3%) and dialysis patients (42.1%)
than in strains isolated from children (5.5%) (P = 0.039

Table 1. Primers used in the study.
Target
genes

Primer sequences (5’ → 3’)

Amplicon
length (bp)

Reference

pap3

GCAACAGCAACGCTGGTTGCATCAT

336

(8)

pap4

AGAGAGAGAACTGGGTGCATCTTAC
1177

(8)

602

(8)

498

(8)

410

(9)

750

(9)

559

(10)

hly1

AACAAGGATAAGCACTGTTCTGGCT

hly2

ACCATATAAGCGGTCATTCCCGTCA

aer1

TACCGGATTGTCATATGCAGACCGT

aer2

AATATCTTCCTCCAGTCCGGAGAAG

cnf1

AAGATGGAGTTTCCTATGCAGGAG

cnf2

CATTCAGAGTCCTGCCCTCATTATT

sfa1

CTCCGGAGAACTGGGTGCATCTTAC

sfa2

CGGAGGAGTAATTACAAACCTGGCA

afa1

GCTGGGCAGCAAACTGATAACTCTC

afa2

CATCAAGCTGTTTGTTCGTCCGCCG

fim1

GAGAAGAGGTTTGATTTAACTTATTG

fim2

AGAGCCGCTGTAGAACTGAGG
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Figure. Antimicrobial resistance of E. coli strains causing
urinary tract infections in hospitalized patients. The designation
of columns with different letters indicates that the percentage
of the resistant strains differs significantly at P ≤ 0.05. AMC
– Amoxicillin plus clavulanic acid, TZP – piperacillin plus
tazobactam, SXT – trimethoprim plus sulfamethoxazole.

and P = 0.001, respectively). The strains showing resistance
to ciprofloxacin were highly significantly more detected
in neurological (30.8%) and internal medicine patients
(25%) than in children (3.7%) (P = 0.002 and P = 0.003,
respectively) (Table 2). ESBLs were expressed by 6 (3.5%)
strains recovered from patients hospitalized in internal (n
= 4) and neurological (n = 2) units.
3.2. Phenotypic characterization of fimbriae
The percentage of strains with type 1 fimbrial expression
was the highest among E. coli isolated from dialysis
patients (86.1%) but the presence of type 1 fimbriae was
not significantly associated with any group of strains (Table
3). MRHA was observed in 82 (47.4%) E. coli strains. The
highest percentage of strains with MRHA was isolated
from children (59.3%). MRHA was significantly more
common in the group of strains from children compared
to the strains isolated from dialysis patients (31.6%) (P =
0.049) (Table 3).
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3.3. Distribution of virulence genes
The fim gene encoding type 1 fimbriae was detected in
160 (92.5%) strains. The presence of sfa and pap genes was
found in 93 (53.8%) and 67 (38.7%) strains, respectively.
The presence of the pap gene was statistically more
frequently detected in E. coli strains isolated from internal
medicine patients (39.1%), children (40.7%), patients
of the neurological ward (42.3%), and pregnant women
(70%) than in strains from dialysis patients (10.5%) (P =
0.0401, P = 0.017, P = 0.022, and P = 0.002, respectively).
Statistical analysis showed that the presence of the sfa gene
was significantly more frequent in strains isolated from
pregnant women (90%) compared to the strains isolated
from patients hospitalized in the internal ward (46.8%)
(P = 0.028), from dialysis patients (52.6%) (P = 0.05),
and from patients hospitalized in the neurological ward
(38.5%) (P = 0.007). The sfa gene was also significantly
more frequently detected in strains isolated from children
(63%) than neurological patients (P = 0.04).
The afa gene was detected in only 4.6% of strains. The
hly gene encoding α-haemolysin was found in 32 (18.5%)
strains and the presence of this gene was significantly more
frequent in strains isolated from dialysis patients (36.8%)
than in strains from internal medicine patients (1.6%) (P
= 0.0002). The hly gene was also detected in the strains
from children (33.3%) and patients from the neurological
ward (23.1%) significantly more than in the strains from
internal medicine patients (P = 0.0002 and P = 0.003,
respectively). The aer gene was detected in 91 (52.6%)
E. coli strains and this gene was significantly more often
detected in the strains isolated from patients hospitalized
in the neurological ward (73.1%) and children (64.8%)
compared to internal medicine patients (34.3%) (P =
0.0009 and P = 0.001, respectively) (Table 3).
3.4. Phylogenetic groups
Among the 173 E. coli strains from patients with UTIs,
66 strains (38.1%) belonged to phylogenetic group B2, 61
(35.3%) to group D, 32 (18.5%) to group A, and 14 (8.1%)
to group B1. More than half of the strains from children
(55.5%) belonged to group B2, significantly more than the
strains from internal medicine patients (P = 0.0007). The
percentage of strains isolated from patients of the obstetric
ward that belonged to phylogenetic group D was 60% and
the frequency of these strains in group D was significantly
higher than the strains from dialysis patients (10.5%) (P
= 0.009). The frequency of strains from dialysis patients
in phylogenetic group D was also significantly lower than
strains from internal medicine patients (43.8%) (P =
0.018) (Table 3).
3.5. Biofilm formation on urinary catheter
Out of 173 strains, moderate and strong biofilm producers
were found to be 45.1% and 37%, respectively. The highest
percentage of strong biofilm producers was among the
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Table 2. Distribution of antimicrobial resistance according to the origin of E. coli strains.
Antimicrobial agents

Number (%) of resistant strains
Internal
n = 64

Pediatrics
n = 54

Neurological
n = 26

Obstetric
n = 10

Dialysis
n = 19

Ampicillin

39a (60.9)

31a (57.4)

15a (57.7)

1b (10.0)

10ab (52.6)

AMC

8 (12.5)

6 (11.1)

5 (19.2)

1 (10.0)

4a (21.0)

Piperacillin

21a (32.8)

4b (7.4)

6ab (23.1)

1ab (10.0)

6a (31.6)

Cephalothin

13 (20.3)

3 (5.5)

6 (23.1)

0 (0.0)

8c (42.1)

Cefuroxime

6a (9.4)

1a (1.8)

2a (7.7)

0a (0.0)

1a (5.3)

Cefotaxime

5 (7.8)

0 (0.0)

1 (3.8)

0 (0.0)

0ab (0.0)

Ceftazidime

6a (9.4)

1a (1.8)

3a (11.5)

1a (100

0a (0.0)

Gentamicin

5 (7.8)

2 (3.7)

2 (7.7)

0 (0)

0a (0)

Ciprofloxacin

16a (25.0)

2b (3.7)

8a (30.8)

2ab (20.0)

5ab (26.3)

Tetracycline

31 (48.4)

18 (33.3)

10 (38.5)

1 (10.0)

8a (42.1)

SXT

13ab (20.3)

7b (13.0)

10ac (38.5)

2ab (20.0)

5ab (26.3)

Nitrofurantoin

6a (9.4)

0a (0.0)

0a (0.0)

0a (0.0)

0a (0.0)

a

a

ac

a

b

a

abc

b

a

ab

ab

a

a

a

ab

a

a

a

a

a

AMC – Amoxicillin plus clavulanic acid; SXT – trimethoprim plus sulfamethoxazole.
The designation with different letters indicates that number of resistant strains differs significantly among patients from
different hospital wards at P ≤ 0.05.
Table 3. Distribution of MSHA and MRHA fimbriae, virulence genes, and phylogenetic groups according to the origin
of E. coli strains.
Number (%) of strains with trait
Internal
n = 64

Pediatrics
n = 54

Neurological
n = 26

Obstetric
n = 10

Dialysis
n = 19

MSHA

55a (85.9)

47a (87.0)

21a (80.8)

8a (80.0)

18a (94.7)

MRHA

28ab (43.7)

32b (59.3)

11ab (42.3)

5ab (50.0)

6a (31.6)

pap

25a (39.1)

22a (40.7)

11a (42.3)

7a (70.0)

2b (10.5)

sfa

30 (46.8)

34

10 (38.5)

9 (90.0)

10ad (52.6)

fim

58a (90.6)

51a (94.4)

25a (96.2)

8a (80.0)

18a (94.7)

afa

2 (3.1)

1 (1.8)

4 (15.4)

0 (0.0)

1a (5.3)

hly

1a (1.6)

18b (33.3)

6b (23.1)

0ab (0.0)

7b (36.8)

cnf

11 (17.2)

4 (7.4)

1 (3.8)

2 (20.0)

3a (15.8)

aer

22a (34.4)

35bcd (64.8)

19cd (73.1)

5ad (50.0)

10ad (52.6)

A

14a (21.9)

7a (13.0)

5a (19.2)

1a (10)

5a (26.3)

B1

6a (9.4)

0b (0.0)

4a (15.4)

1ab (10)

3a (15.8)

B2

16 (25.0)

30 (55.5)

9 (34.6)

2 (20.0)

9ab (47.4)

D

28a (43.8)

17ab (31.5)

8ab (30.8)

6a (60.0)

2b (10.5)

Trait
Fimbriae

Genes
ab

a

a

bcd

(63.0)

a

a

a

a

a

c

a

a

Phylogeny

a

b

ab

ab

The designation with different letters indicates that number of strains with the particular trait differs significantly among
patients from different hospital wards at P ≤ 0.05.
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antimicrobial resistance of urinary E. coli isolates to this
agent (14,16,17). This trend has continued for decades
and the increasing resistance of E. coli to trimethoprim
plus sulfamethoxazole can be explained by frequent use
of this antimicrobial agent because it is recommended
as the second-line drug in treating acute uncomplicated
cystitis in women. The level of resistance of E. coli
strains to first-generation cephalosporins (cephalothin)
was highly significantly higher than those for second(cefuroxime) and third-generation cephalosporins
(cefotaxime, ceftazidime) and results of our investigation
were consistent with those obtained by other authors
(16). Authors reported low resistance rates of E. coli to
nitrofurantoin (0.85%–1.6%) (14,16) or that all strains
were sensitive to this antimicrobial agent (15) and that in
the last decade no increase in resistance was observed. In
our research, the resistance rates to nitrofurantoin were
higher and amounted to 3.5%.
Among 7 virulence genes studied, the fim gene,
which encodes type 1 fimbriae, was the most frequently
detected. The role of type 1 fimbriae in human disease
is difficult to reconcile because they are present in both
pathogenic and commensal isolates (18). The pap gene
(pyelonephritis-associated pili) was present in about 39%
of E. coli strains but among strains isolated from pregnant
women the percentage of strains with this gene was 70%.
Similar results were obtained by Naveen and Mathai (19),
who showed that P fimbriae in isolates from pregnant
women were identified significantly more frequently than
in isolates from other groups of patients. In this study,
only 10.5% of strains isolated from dialysis patients had
the pap gene and the frequency of this gene among these
strains was significantly less than among strains isolated
from other groups of patients. This might have resulted
from the fact that adherence mediated by P fimbriae
might be less important when the defenses of the urinary
tract against infection are compromised by anatomic
abnormality. About 50% of uropathogenic E. coli isolates
show the α-hemolysin gene and its expression is associated

strains isolated from patients of the neurological (61.5%),
obstetric (60%), and dialysis (52.6%) wards (Table 4).
No association of the degree of biofilm formed with
adhesin and toxin genes and expression of the mannoseresistant or mannose-sensitive fimbriae was found. The
strains that differed in degree of biofilm formation on
catheter surfaces were not associated with any of the
phylogenetic groups. Only the aerobactin gene was highly
significantly associated with strong biofilm-producing E.
coli strains (Table 5).
4. Discussion
Antimicrobial resistance among E. coli causing UTIs is
increasing in many countries around the world (13). In
this study, 55.5% of strains were resistant to ampicillin
and this was similar to results of other authors, who found
that 56% of E. coli isolates from hospitalized patients in
Turkey showed resistance to this antibiotic (14). We found
that resistance rates to ampicillin were significantly higher
than to other antibiotics but among strains isolated from
pregnant women were significantly lower than among
strains isolated from patients of internal, neurological, or
pediatric wards. A low level of antimicrobial resistance
among strains from pregnant women may be associated
with reduced use of antibiotics in pregnancy and relatively
short stay in the hospital. In our research, a high level of
resistance to tetracycline (above 39%) was also found. An
even higher percentage (67.3%) of E. coli strains resistant
to this antibiotic was isolated at the same time from people
with UTIs from different parts of India (15).
The resistance to ciprofloxacin among our isolates was
higher (19.1%) than among isolates from Turkey (15%)
(14). Sanchez et al. (16) suggested that the increasing
of resistance to ciprofloxacin among E. coli strains
was a result of widespread use of this antibiotic in the
treatment of uncomplicated UTIs in the early 2000s. In
the present study over 21% of strains showed resistance
to trimethoprim plus sulfamethoxazole and our result is
consistent with previous reports regarding increases in

Table 4. Ability of E. coli strains to produce biofilm on urinary catheters.
Origin of strains (no.)

No. (%) of strains
Specific biofilm formation

1912

None

Weak

Moderate

Strong

Internal (64)

1 (1.6)

19 (29.7)

32 (50)

12 (18.7)

Pediatric (54)

0

9 (16.7)

25 (46.3)

20 (37)

Neurological (26)

0

1 (3.8)

9 (34.6)

16 (61.5)

Obstetric (10)

0

0

4 (40)

6 (60)

Dialysis (19)

0

1 (5.3)

8 (42.1)

10 (52.6)
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Table 5. Distribution of virulence determinants and phylogenetic groups according to ability
of biofilm formation by E. coli.
Trait

No. (%) of strains

P-value

Strong biofilm
producers (n = 64)

Moderate, weak, and no
biofilm producers (n = 109)

MSHA

53 (82.8)

95 (87.2)

0.347

MRHA

30 (46.8)

52 (47.7)

0.909

pap

28 (43.7)

39 (35.8)

0.315

sfa

31 (48.4)

62 (56.9)

0.386

fim

59 (92.2)

101 (92.6)

0.919

afa

5 (7.8)

3 (2.7)

0.118

hly

16 (25.0)

16 (14.7)

0.077

cnf

6 (10.6)

15 (19.4)

0.439

41 (64.1)

49 (44.9)

0.028

A

14 (16.9)

18 (19.4)

0.387

B1

5 (7.8)

9 (8.25)

0.763

B2

21 (32.8)

45 (41.3)

0.371

D

22 (34.4)

39 (35.8)

0.871

Fimbriae

Adhesin genes

Toxin genes

Aerobactin gene
aer
Phylogeny

with increased clinical severity in patients (1). Our results
showed that the hly gene was highly significantly more
often identified in E. coli strains isolated from dialysis
and neurological patients and from children than among
strains from patients hospitalized in the internal ward.
Approximately one-third of uropathogenic E. coli strains
encode CNF1, which can promote apoptosis of bladder
epithelial cells and stimulate their exfoliation, which
enhances bacterial access to underlying tissue (1). In this
study, the presence of the cnf gene was found only in
over 12% of strains, which was consistent with the results
obtained by Tiba et al. (20). Urine is poor in iron, and
uropathogenic E. coli produces a number of iron-chelating
factors (siderophores), including aerobactin (1). Our
results revealed that 52.6% of strains had the aer gene.
In this study, we also investigated the presence of genes
encoding S fimbriae. The sfa gene was detected in above
54% of strains, as similarly observed by other authors (21).
Most strains belonged to the B2 and D phylogenetic
groups and our results agree with other studies concerning
phylogenetic lines in uropathogenic E. coli (22). In
this study, phylogenetic group B2 of strains was highly
significantly associated with children, while strains
belonging to the D group were associated with pregnant
women and internal medicine patients. The strains

belonging to the A phylogenetic group were not associated
with any group of patients, as similarly observed by
Clermont et al. (11).
In our study, an association between the degree of
biofilm formed and the presence of adhesion, toxin
genes, or expression of MSHA and MRHA was not found.
However, we found that the presence of the aer gene was
significantly associated with our strains producing strong
biofilm. This indicates that high potential of biofilm
formation is related to the possession of an iron acquisition
system and production of siderophore aerobactin that
maintains metabolic activity and makes proliferation of
bacteria in biofilm possible.
In conclusion, analysis of the antimicrobial resistance
of E. coli strains showed a high level of resistance to
ampicillin and tetracycline. We observed association of
resistance to antibiotics with the origin of the strains.
No significant association between the degree of biofilm
formed and the presence of adhesion and toxin genes was
found. A high potential for biofilm formation seems to
be associated with the presence of the aer gene encoding
siderophore aerobactin. Further studies involving larger
numbers of clinical strains are required with regard to the
influence of the aerobactin-mediated iron uptake system
on the potential for biofilm formation.
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